**Core Concept**
The main aim of an adjuvant in immunology and vaccine development is to augment or enhance the immune response to a specific antigen. Adjuvants work by activating immune cells, such as dendritic cells, and modulating the immune response to increase the production of antibodies and T-cell responses.

**Why the Correct Answer is Right**
Adjuvants stimulate the immune system by activating pattern recognition receptors (PRRs) on immune cells, such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs). This activation leads to the release of pro-inflammatory cytokines, which in turn activate immune cells to produce antibodies and T-cells. Adjuvants can also increase the phagocytic activity of immune cells, such as macrophages and neutrophils, to engulf and eliminate pathogens.

**Why Each Wrong Option is Incorrect**
**Option A:** The main aim of an adjuvant is not to decrease the immune response, but rather to enhance it. Adjuvants are used to stimulate the immune system, not suppress it.
**Option B:** While adjuvants can increase the production of antibodies, this is not their primary aim. Adjuvants work by activating the immune system to produce a broader immune response, including both humoral and cellular immunity.
**Option C:** Adjuvants do not primarily work by increasing the absorption of antigens. While adjuvants can enhance the delivery of antigens to immune cells, their primary mechanism of action is to stimulate the immune response.

**Clinical Pearl / High-Yield Fact**
Adjuvants are used in a wide range of vaccine formulations, including influenza, HPV, and hepatitis B vaccines. They are also used in some therapeutic settings, such as cancer immunotherapy, to enhance the immune response to tumor antigens.

**Correct Answer: B. Increase the immune response to a specific antigen.**